BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Pancreatic cancer AND PTPRC, LCA, 5788, ENSG00000081237, T200, GP180, B220, LY5, CD45 AND Prognosis
19 results:

  • 1. APOBEC3C is a novel target for the immune treatment of lower-grade gliomas.
    Zhao S; Li Y; Xu J; Shen L
    Neurol Res; 2024 Mar; 46(3):227-242. PubMed ID: 38007705
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Spatially restricted tumour-associated and host-associated immune drivers correlate with the recurrence sites of pancreatic cancer.
    Karamitopoulou E; Wenning AS; Acharjee A; Zlobec I; Aeschbacher P; Perren A; Gloor B
    Gut; 2023 Aug; 72(8):1523-1533. PubMed ID: 36792355
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Correlation between drug sensitivity profiles of circulating tumour cell-derived organoids and clinical treatment response in patients with pancreatic ductal adenocarcinoma.
    Wu YH; Hung YP; Chiu NC; Lee RC; Li CP; Chao Y; Shyr YM; Wang SE; Chen SC; Lin SH; Chen YH; Kang YM; Hsu SM; Yen SH; Wu JY; Lee KD; Tseng HE; Tsai JR; Tang JH; Chiou JF; Burnouf T; Chen YJ; Wang PY; Lu LS
    Eur J Cancer; 2022 May; 166():208-218. PubMed ID: 35306319
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Tumour infiltrating lymphocytes and immune-related genes as predictors of outcome in pancreatic adenocarcinoma.
    D'Angelo A; Sobhani N; Roviello G; Bagby S; Bonazza D; Bottin C; Giudici F; Zanconati F; De Manzini N; Guglielmi A; Generali D
    PLoS One; 2019; 14(8):e0219566. PubMed ID: 31381571
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Integrated multiomic analysis reveals comprehensive tumour heterogeneity and novel immunophenotypic classification in hepatocellular carcinomas.
    Zhang Q; Lou Y; Yang J; Wang J; Feng J; Zhao Y; Wang L; Huang X; Fu Q; Ye M; Zhang X; Chen Y; Ma C; Ge H; Wang J; Wu J; Wei T; Chen Q; Wu J; Yu C; Xiao Y; Feng X; Guo G; Liang T; Bai X
    Gut; 2019 Nov; 68(11):2019-2031. PubMed ID: 31227589
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Identification of key pathways and gene changes in primary pancreatic stellate cells after cross-talk with pancreatic cancer cells (BXPC-3) using bioinformatics analysis.
    Tang D; Wu Q; Yuan Z; Xu J; Zhang H; Jin Z; Zhang Q; Xu M; Wang Z; Dai Z; Fang H; Li Z; Lin C; Shi C; Xu M; Sun X; Wang D
    Neoplasma; 2019 May; 66(3):446-458. PubMed ID: 30784291
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Analogous detection of circulating tumor cells using the AccuCyte
    van der Toom EE; Groot VP; Glavaris SA; Gemenetzis G; Chalfin HJ; Wood LD; Wolfgang CL; de la Rosette JJMCH; de Reijke TM; Pienta KJ
    Prostate; 2018 Mar; 78(4):300-307. PubMed ID: 29285777
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Clinical significance of pancreatic circulating tumor cells using combined negative enrichment and immunostaining-fluorescence in situ hybridization.
    Gao Y; Zhu Y; Zhang Z; Zhang C; Huang X; Yuan Z
    J Exp Clin Cancer Res; 2016 Apr; 35():66. PubMed ID: 27066900
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Development of a Novel c-MET-Based CTC Detection Platform.
    Zhang T; Boominathan R; Foulk B; Rao C; Kemeny G; Strickler JH; Abbruzzese JL; Harrison MR; Hsu DS; Healy P; Li J; Pi C; Prendergast KM; Hobbs C; Gemberling S; George DJ; Hurwitz HI; Connelly M; Garcia-Blanco MA; Armstrong AJ
    Mol Cancer Res; 2016 Jun; 14(6):539-47. PubMed ID: 26951228
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Circulating Tumor Cell Phenotype Predicts Recurrence and Survival in pancreatic Adenocarcinoma.
    Poruk KE; Valero V; Saunders T; Blackford AL; Griffin JF; Poling J; Hruban RH; Anders RA; Herman J; Zheng L; Rasheed ZA; Laheru DA; Ahuja N; Weiss MJ; Cameron JL; Goggins M; Iacobuzio-Donahue CA; Wood LD; Wolfgang CL
    Ann Surg; 2016 Dec; 264(6):1073-1081. PubMed ID: 26756760
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Circulating tumor cells (Ctc) and kras mutant circulating free Dna (cfdna) detection in peripheral blood as biomarkers in patients diagnosed with exocrine pancreatic cancer.
    Earl J; Garcia-Nieto S; Martinez-Avila JC; Montans J; Sanjuanbenito A; Rodríguez-Garrote M; Lisa E; Mendía E; Lobo E; Malats N; Carrato A; Guillen-Ponce C
    BMC Cancer; 2015 Oct; 15():797. PubMed ID: 26498594
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. SELEX aptamer used as a probe to detect circulating tumor cells in peripheral blood of pancreatic cancer patients.
    Zhang J; Li S; Liu F; Zhou L; Shao N; Zhao X
    PLoS One; 2015; 10(3):e0121920. PubMed ID: 25799539
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Huge undifferentiated carcinoma of the pancreas with osteoclast-like giant cells.
    Jo S
    World J Gastroenterol; 2014 Mar; 20(10):2725-30. PubMed ID: 24627610
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Human pancreatic cancer contains a side population expressing cancer stem cell-associated and prognostic genes.
    Van den Broeck A; Vankelecom H; Van Delm W; Gremeaux L; Wouters J; Allemeersch J; Govaere O; Roskams T; Topal B
    PLoS One; 2013; 8(9):e73968. PubMed ID: 24069258
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Circulating tumor cells in melanoma patients.
    Clawson GA; Kimchi E; Patrick SD; Xin P; Harouaka R; Zheng S; Berg A; Schell T; Staveley-O'Carroll KF; Neves RI; Mosca PJ; Thiboutot D
    PLoS One; 2012; 7(7):e41052. PubMed ID: 22829910
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Analysis of microvessels in pancreatic cancer: by light microscopy, confocal laser scan microscopy, and electron microscopy.
    Takagi K; Takada T; Amano H; Yoshida M; Miura H; Toyota N; Wada K; Takahashi I
    J Hepatobiliary Pancreat Surg; 2008; 15(4):384-90. PubMed ID: 18670839
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Ductal adenocarcinoma of the pancreas with huge cystic degeneration: a lesion to be distinguished from pseudocyst and mucinous cystadenocarcinoma.
    Lee LY; Hsu HL; Chen HM; Hsueh C
    Int J Surg Pathol; 2003 Jul; 11(3):235-9. PubMed ID: 12894360
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Tumors of the pancreas with osteoclast-like and pleomorphic giant cells: an immunohistochemical and ploidy study.
    Deckard-Janatpour K; Kragel S; Teplitz RL; Min BH; Gumerlock PH; Frey CF; Ruebner BH
    Arch Pathol Lab Med; 1998 Mar; 122(3):266-72. PubMed ID: 9823867
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Osteoclast-like giant cell tumor of the pancreas with metastases to gallbladder and lymph nodes. A case report.
    Sun AP; Ohtsuki Y; Liang SB; Sonobe H; Iwata J; Furihata M; Takeuchi T; Qiu Y; Chen BK; Watanabe R; Ohmori K
    Pathol Res Pract; 1998; 194(8):587-94; discussion 595. PubMed ID: 9779494
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.